Infinium Pharmachem Ltd Financials
Company Logo

Infinium Pharmachem Ltd Financial Statement

Infinium Pharmachem Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Invest in Infinium Pharmachem Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Infinium Pharmachem Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual122.36
Operating Expenses Annual104.94
Operating Profit Annual19.04
Interest Annual1.78
Depreciation2.41
Net Profit Annual11.09
Tax Annual3.77

Infinium Pharmachem Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning3.32
Cash Flow from Operations-15.03
Cash Flow from Investing-3.29
Cash Flow from Financing23.19
Cash Flow at the End8.18

Infinium Pharmachem Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)15.57
PBIT Margin (%)13.60
PBT Margin (%)5.96
Net PROFIT Margin (%)9.06
Return On Networth / Equity (%)27.91
Return On Networth /Employed (%)29.32
Return On Assets (%)19.58
Total Debt / Equity (X)0.43
Asset Turnover Ratio (%)2.16

Infinium Pharmachem Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual16.47
Total Current Assets Annual60.23
Non Current Assets Annual17.51
Total Shareholders Funds Annual57.75
Total Assets Annual77.74

Infinium Pharmachem Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 23, 2024, Infinium Pharmachem Ltd has a market capitalization of 318.68 Cr. Value Research classifies it as a Small-Cap company.
Yes, Infinium Pharmachem Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Infinium Pharmachem Ltd recorded a total revenue of approximately 122.36 Cr marking a significant milestone in the company's financial performance.
Infinium Pharmachem Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.3% annually, respectively..
Infinium Pharmachem Ltd's current PE ratio is 28.74.
Infinium Pharmachem Ltd's ROCE averaged 37.7% from the FY ending March 2022 to 2024, with a median of 34.6%. It peaked at 52.0% in March 2023, reflecting strong capital efficiency over the period..
Infinium Pharmachem Ltd's latest EBIT is Rs. 16.64 Cr, surpassing the average EBIT of Rs. 13.66 Cr over the 5 years..